CLINICAL_TRIALS
trial_result
· 2015-04-02
Clinical Trial Update: Phase 2 Study of Neoadjuvant Vemurafenib in Melanoma Patients With Untreated Brain Metastases [Phase 2]
Summary
This entry reports the completion and posted results of a Phase 2 neoadjuvant trial evaluating vemurafenib in melanoma patients with untreated brain metastases.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2015-04-02